Transarterial Embolization Alone Versus Drug-Eluting Microspheres Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE): A Multicenter Randomized Clinical Trial
CardioVascular and Interventional Radiology · 2026
DOI: 10.1007/s00270-026-04487-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CardioVascular and Interventional Radiology, 2026. Verfasst von Cristina Mosconi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Embolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agenzia Italiana del Farmaco, Ministero della Salute.
Abstract (Originalsprache)
Purpose
To compare transarterial embolization (TAE) and drug-eluting microspheres transarterial chemoembolization (DEM-TACE) in the treatment of hepatocellular carcinoma (HCC) through a non-inferiority randomized clinical trial. Materials and Methods Patients diagnosed with unresectable HCC were randomly assigned to either the TAE or DEM-TACE group. The primary endpoint was time to progression (TTP), and secondary endpoints included overall survival, hospitalization stay, tumor response rates, and severe adverse events (SAE).
Results
At the end of the trial, a total of 111 patients (56 TAE and 55 DEM-TACE) were enrolled between 2019 and 2022. The median TTP was similar between TAE and DEM-TACE (7.56 vs. 7.98 months, p = 0.432). In patients with confirmed disease progression, the mean TTP was 6.68 vs. 8.43 months for TAE and DEM-TACE, respectively, with a mean difference of 1.75 months (95% CI − 1.47–4.97), falling within the predefined equivalence range; two one side test (TOST) analysis confirmed equivalence ( p < 0.001 and p = 0.022 for lower and upper bounds. Overall survival, tumor response rates, and adverse events were also not statistically different between groups ( p > 0.05 for each outcome). Finally, Days of hospitalization were not statistically different (median 4 days for both arms, p = 0.638).
Conclusion
TAE and DEM-TACE had comparable results in the treatment of early and intermediate stage unresectable HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy.
- Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
- Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy. makoto.taninokuchitomassoni@aosp.bo.it.
- Epidemiology and Statistics, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
- Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy.
- Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milano Vita Salute San Raffaele University, Milan, Italy.
Förderung
- Agenzia Italiana del Farmaco, Ministero della Salute
Zitieren
APA
Mosconi, C., Taninokuchi Tomassoni, M., Zanella, S., Paccapelo, A., Marasco, G., Gusmini, S., Ratti, F., Palumbo, D., Sironi, S., Muglia, R., Fronda, M. M. E., Calandri, M., Fonio, P., Marra, P., Doriguzzi Breatta, A., Cucchetti, A., De Cobelli, F., & Renzulli, M. (2026). Transarterial Embolization Alone Versus Drug-Eluting Microspheres Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE): A Multicenter Randomized Clinical Trial. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-026-04487-3
Vancouver
Mosconi C, Taninokuchi Tomassoni M, Zanella S, Paccapelo A, Marasco G, Gusmini S, et al. Transarterial Embolization Alone Versus Drug-Eluting Microspheres Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE): A Multicenter Randomized Clinical Trial. CardioVascular and Interventional Radiology. 2026. doi:10.1007/s00270-026-04487-3
BibTeX
@article{Mosconi2026,
author = {Mosconi, Cristina and Taninokuchi Tomassoni, Makoto and Zanella, Sara and Paccapelo, Alexandro and Marasco, Giovanni and Gusmini, Simone and Ratti, Francesca and Palumbo, Diego and Sironi, Sandro and Muglia, Riccardo and Fronda, Marco Mario Edgardo and Calandri, Marco and Fonio, Paolo and Marra, Paolo and Doriguzzi Breatta, Andrea and Cucchetti, Alessandro and De Cobelli, Francesco and Renzulli, Matteo},
title = {Transarterial Embolization Alone Versus Drug-Eluting Microspheres Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE): A Multicenter Randomized Clinical Trial},
journal = {CardioVascular and Interventional Radiology},
year = {2026},
doi = {10.1007/s00270-026-04487-3}
}
EUVIMED